AUTOSurv: Interpretable Deep Learning Framework for Cancer Survival Analysis Incorporating Clinical and Multi-omics Data

Author:

Jiang Lindong1ORCID,Xu Chao2ORCID,Bai Yuntong1,Liu Anqi1,Gong Yun1,Wang Yu-Ping3ORCID,Deng Hong-Wen1ORCID

Affiliation:

1. Tulane University

2. University of Oklahoma Health Sciences Center

3. Department of Biomedical Engineering, Tulane University

Abstract

Abstract Accurate prognosis for cancer patients can provide critical information for optimizing treatment plans and improving life quality. Combining omics data and demographic/clinical information can offer a more comprehensive view of cancer prognosis than using omics or clinical data alone and can reveal the underlying disease mechanisms at the molecular level. In this study, we developed a novel deep learning framework to extract information from high-dimensional gene expression and miRNA expression data and conduct prognosis prediction for breast cancer and ovarian cancer patients. Our model achieved significantly better prognosis prediction than the conventional Cox Proportional Hazard model and other competitive deep learning approaches in various settings. Moreover, an interpretation approach was applied to tackle the “black-box” nature of deep neural networks and we identified features (i.e., genes, miRNA, demographic/clinical variables) that made important contributions to distinguishing predicted high- and low-risk patients. The identified associations were partially supported by previous studies.

Publisher

Research Square Platform LLC

Reference69 articles.

1. Cox-nnet: an artificial neural network method for prognosis prediction of high-throughput omics data;Ching T;PLoS computational biology,2018

2. Cancer statistics, 2022;Siegel RL;CA Cancer J Clin,2022

3. Simple prognostic model for patients with advanced cancer based on performance status;Jang RW;Journal of Oncology Practice,2014

4. Machine learning applications in cancer prognosis and prediction;Kourou K;Computational and structural biotechnology journal,2015

5. Automated model versus treating physician for predicting survival time of patients with metastatic cancer;Gensheimer MF;Journal of the American Medical Informatics Association,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3